E2A-PBX1 One-Step Detection Kit - MBS BIOTECHNOLOGY COMPANY LIMITTED

E2A-PBX1 One-Step Detection Kit - MBS BIOTECHNOLOGY COMPANY LIMITTED

E2A-PBX1 One-Step Detection Kit - MBS BIOTECHNOLOGY COMPANY LIMITTED

E2A-PBX1 One-Step Detection Kit - MBS BIOTECHNOLOGY COMPANY LIMITTED

E2A-PBX1 One-Step Detection Kit - MBS BIOTECHNOLOGY COMPANY LIMITTED
E2A-PBX1 One-Step Detection Kit - MBS BIOTECHNOLOGY COMPANY LIMITTED
  • Oncological Mutation Analysis
Product details

E2A-PBX1 One-Step Detection Kit

One-step Real Time PCR kit for quantitative detection of E2A-PBX1 t(1;19)(q23;p13) fusion transcript in patients who have been diagnosed with hematologic malignancies.
Specifications
Information
Video
Download

- Certificate: CE-IVD

- Description: Chromosomal translocation E2A-PBX1 t(1;19)(q23;p13) occurs with frequency 3-5% in children with precursor-B-ALL (ALL) and 3% in adult precursor-B-ALL. This test can be used to monitor Minimal Residual Disease (MRD) in patients undergoing therapy.

- Sample material: total RNA isolated from bone marrow or peripheral blood.

- E2A-PBX1 fusion transcript is detected on FAM channel and Internal control on HEX/VIC channel.

- Validated on: ABI (7500, 7900HT, StepOne, StepOne Plus); Rotor-Gene (Q, 3000, 6000); LightCycler 480

 

backtop